MOTS-c Research Guide: Mitochondrial Peptide, AMPK Activation & Metabolic Studies

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16-amino acid mitochondrial-derived peptide (MDP) discovered by Chang Lee and colleagues at the University of Southern California and published in Cell Metabolism in 2015. Its discovery represented a paradigm shift in biology: unlike virtually all other peptides, MOTS-c is encoded not by nuclear DNA but by the mitochondrial genome, specifically within the 12S ribosomal RNA region of mtDNA. This mitochondrial origin, combined with MOTS-c’s potent effects on AMPK signaling, insulin sensitivity, and metabolic flexibility, has generated substantial research interest in MOTS-c as a potential metabolic regulator and exercise-mimetic research tool compound.

For research use only. Not intended for human or veterinary use.

Background: Mitochondrial-Derived Peptides

The discovery that the mitochondrial genome, long thought to encode only 13 proteins, 22 tRNAs, and 2 rRNAs for oxidative phosphorylation, could also encode bioactive signaling peptides opened a new field in cellular biology. The first mitochondrial-derived peptide identified was humanin (2003), followed by MOTS-c (2015) and small humanin-like peptides (SHLPs 1–6, 2016). These MDPs appear to function as retrograde signals from mitochondria to the nucleus and to other cells, communicating mitochondrial status to systemic regulators of metabolism, stress response, and aging.

MOTS-c is particularly notable because its amino acid sequence is conserved across vertebrate species, an unusual feature for mitochondrial-encoded sequences, suggesting functional importance under evolutionary selection pressure.

Structure and Properties

• Sequence: MRWQEMGYIFYPRKLR (16 amino acids)
• Molecular weight: 2,174 Da
• Origin: Encoded in the 12S rRNA region of human mitochondrial DNA (mtDNA)
• Circulating levels: Detectable in human plasma; levels decline with age and increase with exercise in some studies
• Nuclear translocation: Under conditions of metabolic stress, MOTS-c translocates from the cytoplasm to the nucleus, where it acts as a transcriptional regulator, a property unique among mitochondrial peptides

Mechanism of Action

AMPK Activation and Metabolic Reprogramming

The primary characterized mechanism of MOTS-c is activation of AMP-activated protein kinase (AMPK), the master cellular energy sensor. AMPK is activated when cellular AMP:ATP ratios increase (energy stress), triggering a shift toward catabolic energy-generating pathways: increased fatty acid oxidation, enhanced glucose uptake via GLUT4 translocation, reduced mTOR/anabolic signaling, and upregulation of mitochondrial biogenesis (via PGC-1α). Lee et al. (2015) demonstrated that MOTS-c administration activated AMPK in skeletal muscle and adipose tissue, producing metabolic effects consistent with enhanced insulin sensitivity and metabolic flexibility.

Folate-Methionine Cycle Inhibition

A mechanistically distinctive feature of MOTS-c’s AMPK-activating action is its proposed upstream mechanism: inhibition of the folate cycle within the methionine cycle pathway. Lee et al. proposed that MOTS-c interferes with one-carbon metabolism, specifically inhibiting methylenetetrahydrofolate reductase (MTHFR), leading to accumulation of AICAR (an intermediate in purine synthesis that is a potent endogenous AMPK activator). This indirect AMPK activation through metabolic intermediate accumulation distinguishes MOTS-c’s mechanism from direct AMPK activators and connects it to broader one-carbon metabolism research.

Nuclear Translocation and Transcriptional Regulation

Reynolds et al. (2021) demonstrated that MOTS-c translocates to the nucleus in response to metabolic and oxidative stress, where it binds to and regulates stress-responsive nuclear gene promoters, including ARE (antioxidant response element) containing genes. This nuclear activity identifies MOTS-c as more than a signaling peptide: it acts directly as a transcriptional co-regulator, bridging mitochondrial metabolic status with nuclear gene expression programs. This mitochondria-to-nucleus communication role represents the “retrograde signaling” function proposed for MDPs and has broad implications for research into mitochondrial-nuclear crosstalk in aging and stress adaptation.

Exercise Mimetic Properties

Plasma MOTS-c levels increase during exercise in humans, and the peptide’s AMPK-activating metabolic profile overlaps substantially with the cellular adaptations induced by endurance exercise (enhanced mitochondrial biogenesis, increased fatty acid oxidation, improved insulin sensitivity). This profile has led researchers to characterize MOTS-c as a potential “exercise mimetic”, a compound that replicates aspects of exercise’s metabolic benefits through pharmacological means. This is relevant for research into metabolic disease states where exercise capacity is impaired and for mechanistic studies dissecting the molecular underpinnings of exercise adaptation.

Key Research Findings

Insulin Resistance and Obesity

The original 2015 Cell Metabolism paper by Lee et al. demonstrated that MOTS-c administration to diet-induced obese mice and high-fat diet (HFD) mice reversed insulin resistance and reduced fat accumulation, with improved glucose tolerance and insulin sensitivity on par with exercise intervention. Importantly, effects were observed in skeletal muscle, the primary site of insulin-stimulated glucose disposal, consistent with AMPK-driven GLUT4 translocation and enhanced glucose uptake. These findings established MOTS-c as a metabolic research tool compound with potential relevance to type 2 diabetes and obesity research models.

Aging and Age-Related Metabolic Decline

Plasma MOTS-c levels decline with age in both rodents and humans, correlating with the progressive metabolic dysfunction and reduced insulin sensitivity that characterize aging. Lee et al. (2015) reported that MOTS-c administration to aged mice improved metabolic parameters toward those of younger animals, including improved glucose homeostasis and reduced adiposity. Reynolds et al. extended this work by demonstrating that MOTS-c regulates the expression of longevity-associated genes in aged tissues, connecting the mitochondrial-derived peptide to broader aging biology research.

Physical Performance Research

Reynolds et al. (2019) examined MOTS-c’s effects on physical performance in aged mice, reporting significantly improved exercise capacity, measured by grip strength, rotarod performance, and voluntary running distance, in MOTS-c-treated aged mice versus controls. The performance improvements were associated with preserved mitochondrial function and reduced oxidative damage in skeletal muscle. These findings have drawn attention from both the aging research and sports science fields, though the exercise mimetic characterization remains an area of active investigation.

MOTS-c as a Longevity Biomarker

Observational studies have examined MOTS-c plasma levels as a biomarker of metabolic health and aging. One notable study found that exceptionally long-lived individuals (centenarians) had significantly higher plasma MOTS-c levels compared to age-matched controls, consistent with the hypothesis that preserved mitochondrial-derived peptide signaling contributes to healthy aging. While observational associations cannot establish causality, they have motivated mechanistic research into whether maintaining or restoring MOTS-c levels can replicate the longevity-associated metabolic phenotype.

Reconstitution Protocol

MOTS-c is supplied as a lyophilized powder requiring reconstitution with bacteriostatic water prior to research use.

• Inject bacteriostatic water slowly along the inner wall of the vial; do not direct the stream onto the lyophilized powder
• Gently swirl until fully dissolved; solution should be clear and colorless
• Common research concentration: 5 mg/mL
• Refrigerate reconstituted solution at 2–8°C; stable approximately 4 weeks; protect from light
• Do not freeze reconstituted solution; lyophilized powder may be stored at -20°C

References

• Lee, C., Zeng, J., Drew, B. G., Sallam, T., Martin-Montalvo, A., Wan, J., … & Cohen, P. (2015). The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism, 21(3), 443–454.
• Reynolds, J. C., Bhatt, D. L., Lee, C., & Bhatt, D. L. (2021). MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis. Nature Communications, 12(1), 470.
• Kim, S. J., Mehta, H. H., Wan, J., Kuehnemann, C., Chen, J., Hu, J. F., … & Cohen, P. (2018). Mitochondrial peptides modulate mitochondrial function during cellular senescence. Aging, 10(6), 1239–1256.
• Zempo, H., Kim, S. J., Fuku, N., Higashida, K., Wan, J., Sugawara, T., … & Cohen, P. (2021). A pro-diabetogenic mtDNA polymorphism in the mitochondrial peptide MOTS-c. Aging, 13(2), 1692–1717.

All content on this site is intended strictly for in vitro research and laboratory use. Products sold by Exceed Enhancement are not approved by the FDA and are not intended for human consumption, therapeutic use, or veterinary application.

Research-Grade Mots-c Available

Exceed Enhancement offers research-grade Mots-c for qualified research applications. View product specifications and ordering information →